Medication info
Glimem 2/500 mg Tablets

Glimem 2/500 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablets
Packaging
30 tablets/PTP
Approval status
Active

MFDS item code 201107516 · Approved 2011.09.29 · Insurance code 693901210

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Take this medicine 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is usually initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there is experience with gradually increasing the dose according to blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients achieved better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used in combination with glymeperide and metformin to assist in blood sugar control for patients with type 2 diabetes. It helps effectively improve blood sugar management when combined with dietary adjustments and exercise therapy. Therefore, it is a medication that supports patients with type 2 diabetes to better control their blood sugar.

How to take

Adult dose

Take this medicine 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is usually initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there is experience with gradually increasing the dose according to blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients achieved better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia; therefore, it should be discontinued if renal function worsens rapidly. Caution is especially needed if there are signs of dehydration or if the patient is taking medications that may affect kidney function. Patients with cardiovascular disease may have an increased risk of cardiovascular mortality, thus requiring careful monitoring. This medication should not be administered to patients with insulin-dependent diabetes or acute metabolic acidosis. It should also not be used in patients with severely impaired liver function, those on hemodialysis, pregnant women, or nursing mothers. Patients with moderate to severe renal impairment or those undergoing specific tests (e.g., tests requiring iodinated contrast materials) should avoid this medication. Caution should be exercised in patients at high risk for hypoglycemia, such as those with poor nutritional status, irregular eating habits, elderly patients, and those with reduced liver function. Gastrointestinal disturbances may occur during the initial stages of treatment, though these are usually transient. Regular laboratory tests are needed as allergic reactions, blood abnormalities, and vitamin B12 deficiency may arise. This medication can interact with other medications, so it is crucial to inform healthcare providers of any ongoing medications being taken. Pregnant or nursing patients should refrain from taking this medication and switch to insulin therapy if necessary. When administered to children or the elderly, careful observation of kidney function and overall condition is essential. Overdose may result in hypoglycemia, and immediate contact with a healthcare facility and appropriate treatment is required. Regular checks of blood sugar control should be conducted, and if any abnormal symptoms arise, immediate consultation with a physician is needed. Caution is necessary when driving or operating machinery as hypoglycemia or decreased agility may occur. This medication should be stored out of reach of children and should not be transferred to other containers.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal distension, loss of appetite, dyspepsia, constipation, abdominal pain, discomfort, metallic taste, visual impairment, taste disorder, erythema, itching, urticaria, rash, thrombocytopenia, leukopenia, hemolytic anemia, erythropenia, agranulocytosis, pancytopenia, peripheral neuropathy, vitamin B12 deficiency, increased liver enzymes, liver function impairment, cholestasis, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, decreased thyroid-stimulating hormone levels, magnesium deficiency, encephalopathy, hair loss, weight gain, abdominal pain, abdominal distension, vomiting, dyspepsia, palpitations, dizziness, diarrhea, nausea, leg edema, cardiac arrest, rectal carcinoma, vertigo, liver function abnormality, arthralgia, facial edema, erectile dysfunction, flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept tightly closed to protect it from air and moisture, stored safely at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White oblong film-coated tablets

Package unit

30 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.